Top Markets
#1 TENDIES TENDIES +83.50%
#2 Akedo Akedo +81.98%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +43.77%
#5 MultiversX MultiversX +34.16%
#6 Mubarak Mubarak +31.37%
#7 Cash Cat Cash Cat +25.34%
#8 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#9 Bitway Bitway +16.42%
#10 OSK OSK +16.18%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rank in Stocks #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Share Price
$5.84
Last synced: 2025-04-02
Market Cap
$224.09M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Nevro Corp. (NVRO)

Category

Healthcare
Revenue for Nevro Corp. (NVRO)
Revenue in Dec 2024 TTM: $408.52M
According to Nevro Corp. latest financial reports the company's current revenue (TTM) is $408.52M. In 2023 the company made a revenue of $425.17M an increase over the revenue in the year 2022 that was $406.37M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nevro Corp. from 2012 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $408.52M 0.00%
2024 $408.52M -3.92%
2023 $425.17M 4.63%
2022 $406.37M 5.03%
2021 $386.91M 6.87%
2020 $362.05M -7.23%
2019 $390.26M 0.77%
2018 $387.29M 18.56%
2017 $326.67M 42.96%
2016 $228.50M 228.28%
2015 $69.61M 113.69%
2014 $32.57M 38.61%
2013 $23.50M 29.48%
2012 $18.15M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 11,303.41%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 6,224.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 8,586.03%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 5,039.55%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 1,494.13%
US